This event aims to provide an introduction to molecular diagnostic testing and predictive biomarkers as relevant to histopathologists in the diagnosis and reporting primarily of malignancies, to provide an overview of applications of molecular diagnostics in current pathology practice, and to illustrate the relevance of molecular pathology in clinical practice – ‘personalised therapies’, now and in the future.